Knee Osteoarthritis
Conditions
Brief summary
Osteoarthritis (OA) is the most prevalent form of arthritis in the elderly. It is estimated that 7% of men and 11% of women over the age of 65 have KOA. The most significant symptoms of the disease are pain and functional disability. This study has two aims: 1. To characterise the gait patterns and clinical parameters of patients with knee osteoarthritis (KOA) in Singapore at baseline, prior to treatment. 2. To investigate the changes in gait patterns and the clinical benefits of treatment with a new biomechanical device, AposTherapy, for patients with KOA.
Interventions
DEVICEAposTherapy (All Phases of Step-cycle {APOS} system, APOS-Medical and Sports Technologies Ltd. Herzliya, Israel)
Sponsors
Apos Medical and Sports Technology Ltd.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Patients suffering from symptomatic bilateral knee osteoarthritis at the medial compartment for at least six months, fulfilling the ACR clinical criteria for OA of the knee, and having radiographically assessed OA of the knee according to the Kellgren and Lawrence scale. * Patients with an overall WOMAC score of \>2cm (as measured at baseline). * Males and females between the ages of 50-70.
Exclusion criteria
* Patients suffering from acute septic arthritis. * Patients suffering from inflammatory arthritis. * Patients who received a corticosteroid injection within 3 months of the study. * Patients suffering from avascular necrosis of the knee. * Patients with a history of knee buckling or recent knee injury. * Patients who have had a joint replacement. * Patients suffering from neuropathic arthropathy. * Patients with an increased tendency to fall. * Patients exhibiting a lack of physical or mental ability to perform or comply with the study procedure. * Patients with a history of pathological osteoporotic fracture. * Patients suffering from symptomatic degenerative arthritis in lower limb joints other than the knees. * Patients with referred pain in the knees from back or hip joint symptoms.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in self-evaluation questionnaires between baseline and after 6 months of therapy | Baseline, 6 months | Western Ontario and MacMaster osteoarthritis questionnaire (WOMAC) and SF-36 Health Survey will be evaluated. The WOMAC questionnaire is measured on a 10cm visual analogue scale (VAS) and the SF-36 is scored between 0-100. |
Secondary
| Measure | Time frame |
|---|---|
| Changes in spatio-temporal gait parameters between basline and after 6 months of therapy | Baseline, 6 months |
Countries
Singapore
Outcome results
None listed